title: Serum alpha-fetoprotein in the three trimesters of pregnancy: effects of maternal characteristics and medical history.
abstract: OBJECTIVE
  To define the contribution of maternal variables which influence the measured level of maternal serum alpha-fetoprotein (AFP) in screening for pregnancy complications.
  
  
  METHODS
  Maternal characteristics and medical history were recorded and serum AFP was measured in women with a singleton pregnancy attending for three routine hospital visits at 11 + 0 to 13 + 6, 19 + 0 to 24 + 6 and 30 + 0 to 34 + 6 weeks' gestation. For pregnancies delivering phenotypically normal live births or stillbirths ≥ 24 weeks' gestation, variables from maternal demographic characteristics and medical history that are important in the prediction of AFP were determined from a linear mixed-effects multiple regression.
  
  
  RESULTS
  Serum AFP was measured in 17 071 cases in the first trimester, 8583 in the second trimester and 8607 in the third trimester. Significant independent contributions to serum AFP were provided by gestational age, maternal weight, racial origin, gestational age at delivery and birth-weight Z-score of the neonate of the previous pregnancy and interpregnancy interval. Cigarette smoking was found to significantly affect serum AFP in the first trimester only. The machine used to measure serum AFP was also found to have a significant effect. Random-effects multiple regression analysis was used to define the contribution of maternal variables that influence the measured level of serum AFP and express the values as multiples of the median (MoMs). The model was shown to provide an adequate fit of MoM values for all covariates, both in pregnancies that developed pre-eclampsia and in those without this pregnancy complication.
  
  
  CONCLUSIONS
  A model was fitted to express measured serum AFP across the three trimesters of pregnancy as MoMs, after adjusting for variables from maternal characteristics and medical history that affect this measurement.
authors: Harris Birthright Research Centre for Fetal Medicine, King's College Hospital, London, UK.
authors: F E
authors: FE
authors: Bredaki
authors: Harris Birthright Research Centre for Fetal Medicine, King's College Hospital, London, UK.
authors: C
authors: C
authors: Sciorio
authors: Institute of Health Research, University of Exeter, Exeter, UK.
authors: A
authors: A
authors: Wright
authors: Institute of Health Research, University of Exeter, Exeter, UK.
authors: D
authors: D
authors: Wright
authors: Harris Birthright Research Centre for Fetal Medicine, King's College Hospital, London, UK.
authors: K H
authors: KH
authors: Nicolaides
mesh_terms: D000328:Adult; D001724:Birth Weight; D001835:Body Weight; D005006:Ethnicity; D005260:Female; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D008962:Models, Theoretical; D011247:Pregnancy; D011261:Pregnancy Trimester, First / Q000097:blood*; D011262:Pregnancy Trimester, Second / Q000097:blood*; D011263:Pregnancy Trimester, Third / Q000097:blood*; D011446:Prospective Studies; D012044:Regression Analysis; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D012907:Smoking / Q000453:epidemiology; D000509:alpha-Fetoproteins / Q000378:metabolism*
chemical_list: D000509:alpha-Fetoproteins
keywords: alpha-fetoprotein; first-trimester screening; pre-eclampsia; preterm birth; pyramid of pregnancy care; second-trimester screening; third-trimester screening; trisomy 21